Ivacaftor / lumacaftor Alternatives Compared
| Ivacaftor / lumacaftor | Pulmozyme (dornase alfa) | Creon (pancrelipase) |
|
|---|
| Ivacaftor / lumacaftor | Pulmozyme (dornase alfa) | Creon (pancrelipase) |
|
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Cystic Fibrosis. Ivacaftor / lumacaftor may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Cystic Fibrosis. Pulmozyme may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Pancreatic Exocrine Dysfunction, Chronic Pancreatitis, Cystic Fibrosis. Creon may also be used for purposes not listed in this medication guide. |
Related suggestionsCystic Fibrosis |
|||||||||||||||||||
| More about Ivacaftor / lumacaftor | More about Pulmozyme (dornase alfa) | More about Creon (pancrelipase) | ||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||
|
Be the first to share your experience with this drug. |
Pulmozyme has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Creon has an average rating of 6.5 out of 10 from a total of 70 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 26% reported a negative effect. |
||||||||||||||||||||
|
View all 1 reviews |
View all 70 reviews |
|||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||
|
View all side effects |
View all side effects |
View all side effects |
||||||||||||||||||||
| Boxed Warnings A boxed warning is the most serious warning from the Food and Drug Administration (FDA) about drug effects that may be dangerous. | ||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||
| Generic Availability Learn more about brand vs generic drugs. | ||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance. | ||||||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
|
||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||
|
N/A |
|
|
||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||
| Orkambi |
N/A |
Other pancrelipase brands include: Pancreaze, Pertzye, Viokace, Zenpep | ||||||||||||||||||||
| Half Life Learn about the half-life of a drug and how it is calculated. | ||||||||||||||||||||||
|
26 hours |
11 hours |
N/A |
||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||
|
Category B
See the full pregnancy warnings document. |
Category B
See the full pregnancy warnings document. |
Category C
See the full pregnancy warnings document. |
||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||
|
A total of 613 drugs are known to interact with Ivacaftor / lumacaftor:
|
A total of 1 drugs are known to interact with Pulmozyme:
|
A total of 26 drugs are known to interact with Creon:
|
||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||
|
July 2, 2015 |
December 30, 1993 |
N/A |
||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||
| More Information | ||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.